Northern Trust Corp Agios Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 590,108 shares of AGIO stock, worth $32.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
590,108
Previous 586,266 0.66%
Holding current value
$32.9 Million
Previous $25.3 Million 3.71%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$41.19 - $49.72 $158,251 - $191,024
3,842 Added 0.66%
590,108 $26.2 Million
Q2 2024

Aug 14, 2024
SELL
$27.55 - $48.83 $116,453 - $206,404
-4,227 Reduced 0.72%
586,266 $25.3 Million
Q1 2024

May 14, 2024
SELL
$21.32 - $34.81 $634,184 - $1.04 Million
-29,746 Reduced 4.8%
590,493 $17.3 Million
Q4 2023

Feb 13, 2024
BUY
$19.97 - $24.53 $149,775 - $183,975
7,500 Added 1.22%
620,239 $13.8 Million
Q3 2023

Nov 13, 2023
SELL
$24.36 - $28.18 $2.36 Million - $2.73 Million
-96,969 Reduced 13.66%
612,739 $15.2 Million
Q2 2023

Aug 11, 2023
BUY
$21.38 - $29.19 $756,830 - $1.03 Million
35,399 Added 5.25%
709,708 $20.1 Million
Q1 2023

May 15, 2023
SELL
$21.74 - $30.93 $319,751 - $454,918
-14,708 Reduced 2.13%
674,309 $15.5 Million
Q4 2022

Feb 13, 2023
BUY
$24.81 - $31.52 $395,570 - $502,554
15,944 Added 2.37%
689,017 $19.3 Million
Q3 2022

Nov 14, 2022
BUY
$19.51 - $34.14 $2.76 Million - $4.84 Million
141,627 Added 26.65%
673,073 $19 Million
Q2 2022

Aug 12, 2022
SELL
$17.06 - $31.42 $100,261 - $184,655
-5,877 Reduced 1.09%
531,446 $11.8 Million
Q1 2022

May 13, 2022
SELL
$26.68 - $34.81 $2.53 Million - $3.31 Million
-94,964 Reduced 15.02%
537,323 $15.6 Million
Q4 2021

Feb 08, 2022
BUY
$29.58 - $49.78 $817,887 - $1.38 Million
27,650 Added 4.57%
632,287 $20.8 Million
Q3 2021

Nov 15, 2021
SELL
$41.92 - $58.18 $652,065 - $904,989
-15,555 Reduced 2.51%
604,637 $27.9 Million
Q2 2021

Aug 13, 2021
BUY
$52.06 - $61.27 $17.1 Million - $20.1 Million
328,821 Added 112.85%
620,192 $34.2 Million
Q1 2021

May 12, 2021
BUY
$44.23 - $57.5 $242,513 - $315,272
5,483 Added 1.92%
291,371 $15 Million
Q4 2020

Feb 11, 2021
SELL
$33.21 - $46.54 $83,423 - $116,908
-2,512 Reduced 0.87%
285,888 $12.4 Million
Q3 2020

Nov 16, 2020
SELL
$33.87 - $55.93 $554,688 - $915,965
-16,377 Reduced 5.37%
288,400 $10.1 Million
Q2 2020

Aug 14, 2020
SELL
$34.45 - $53.48 $1.16 Million - $1.8 Million
-33,604 Reduced 9.93%
304,777 $16.3 Million
Q1 2020

May 14, 2020
BUY
$31.52 - $53.81 $552,923 - $943,935
17,542 Added 5.47%
338,381 $12 Million
Q4 2019

Feb 14, 2020
BUY
$30.08 - $50.59 $884,983 - $1.49 Million
29,421 Added 10.1%
320,839 $15.3 Million
Q3 2019

Nov 13, 2019
SELL
$32.4 - $49.58 $266,846 - $408,340
-8,236 Reduced 2.75%
291,418 $9.44 Million
Q2 2019

Aug 13, 2019
BUY
$46.17 - $68.1 $2.35 Million - $3.47 Million
50,908 Added 20.47%
299,654 $14.9 Million
Q1 2019

May 13, 2019
BUY
$45.92 - $67.67 $173,210 - $255,251
3,772 Added 1.54%
248,746 $16.8 Million
Q4 2018

Feb 12, 2019
SELL
$42.73 - $76.53 $22,860 - $40,943
-535 Reduced 0.22%
244,974 $11.3 Million
Q3 2018

Nov 14, 2018
SELL
$71.67 - $91.95 $249,411 - $319,986
-3,480 Reduced 1.4%
245,509 $18.9 Million
Q2 2018

Sep 18, 2018
SELL
$73.22 - $99.55 $266,667 - $362,561
-3,642 Reduced 1.44%
248,989 $21 Million
Q2 2018

Aug 14, 2018
SELL
$73.22 - $99.55 $1.21 Million - $1.64 Million
-16,477 Reduced 6.12%
252,631 $21.3 Million
Q1 2018

May 09, 2018
BUY
$59.83 - $86.53 $2.14 Million - $3.09 Million
35,708 Added 15.3%
269,108 $22 Million
Q4 2017

Feb 14, 2018
BUY
$52.12 - $72.33 $248,820 - $345,303
4,774 Added 2.09%
233,400 $13.3 Million
Q3 2017

Nov 13, 2017
BUY
$54.89 - $67.12 $12.5 Million - $15.3 Million
228,626
228,626 $15.3 Million

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email